177 related articles for article (PubMed ID: 30244122)
1. Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power.
Graudenzi A; Maspero D; Di Filippo M; Gnugnoli M; Isella C; Mauri G; Medico E; Antoniotti M; Damiani C
J Biomed Inform; 2018 Nov; 87():37-49. PubMed ID: 30244122
[TBL] [Abstract][Full Text] [Related]
2. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
3. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
Sundaramurthy G; Eghbalnia HR
Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
[TBL] [Abstract][Full Text] [Related]
4. Integration of single-cell RNA-seq data into population models to characterize cancer metabolism.
Damiani C; Maspero D; Di Filippo M; Colombo R; Pescini D; Graudenzi A; Westerhoff HV; Alberghina L; Vanoni M; Mauri G
PLoS Comput Biol; 2019 Feb; 15(2):e1006733. PubMed ID: 30818329
[TBL] [Abstract][Full Text] [Related]
5. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers.
Mandel J; Wang H; Normolle DP; Chen W; Yan Q; Lucas PC; Benos PV; Prochownik EV
BMC Cancer; 2019 Jul; 19(1):686. PubMed ID: 31299925
[TBL] [Abstract][Full Text] [Related]
7. Integrative pathway enrichment analysis of multivariate omics data.
Paczkowska M; Barenboim J; Sintupisut N; Fox NS; Zhu H; Abd-Rabbo D; Mee MW; Boutros PC; ; Reimand J;
Nat Commun; 2020 Feb; 11(1):735. PubMed ID: 32024846
[TBL] [Abstract][Full Text] [Related]
8. Sequential analysis of transcript expression patterns improves survival prediction in multiple cancers.
Mandel J; Avula R; Prochownik EV
BMC Cancer; 2020 Apr; 20(1):297. PubMed ID: 32264880
[TBL] [Abstract][Full Text] [Related]
9. Identification of expression patterns in the progression of disease stages by integration of transcriptomic data.
Aibar S; Abaigar M; Campos-Laborie FJ; Sánchez-Santos JM; Hernandez-Rivas JM; De Las Rivas J
BMC Bioinformatics; 2016 Nov; 17(Suppl 15):432. PubMed ID: 28185568
[TBL] [Abstract][Full Text] [Related]
10. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
11. Integration of transcriptomic data in a genome-scale metabolic model to investigate the link between obesity and breast cancer.
Granata I; Troiano E; Sangiovanni M; Guarracino MR
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):162. PubMed ID: 30999849
[TBL] [Abstract][Full Text] [Related]
12. Network based stratification of major cancers by integrating somatic mutation and gene expression data.
He Z; Zhang J; Yuan X; Liu Z; Liu B; Tuo S; Liu Y
PLoS One; 2017; 12(5):e0177662. PubMed ID: 28520777
[TBL] [Abstract][Full Text] [Related]
13. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression Integration into Pathway Modules Reveals a Pan-Cancer Metabolic Landscape.
Cubuk C; Hidalgo MR; Amadoz A; Pujana MA; Mateo F; Herranz C; Carbonell-Caballero J; Dopazo J
Cancer Res; 2018 Nov; 78(21):6059-6072. PubMed ID: 30135189
[TBL] [Abstract][Full Text] [Related]
15. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
16. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide isoform-level analysis reveals tumor-specific isoforms for lung adenocarcinoma diagnosis and prognosis.
Zhuhong H; Zhenyu B; Xiangyuan C; Tingzhen X; Libin S
Cancer Genet; 2019 Jan; 230():58-65. PubMed ID: 30470588
[TBL] [Abstract][Full Text] [Related]
18. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
19. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.
Wikoff WR; Grapov D; Fahrmann JF; DeFelice B; Rom WN; Pass HI; Kim K; Nguyen U; Taylor SL; Gandara DR; Kelly K; Fiehn O; Miyamoto S
Cancer Prev Res (Phila); 2015 May; 8(5):410-8. PubMed ID: 25657018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
